Development of an all-human vascularized model of pancreatic islets on-chip: towards personalized medicine for type 1 diabetes - France Génomique Access content directly
Conference Papers Year : 2024

Development of an all-human vascularized model of pancreatic islets on-chip: towards personalized medicine for type 1 diabetes

Abstract

Diabetes is a chronic disease characterized by a persistent elevation of blood glucose levels, resulting from either insulin deficiency (Type 1 diabetes) or insulin resistance (Type 2 diabetes). In 2021, diabetes affected one in eleven people globally and was responsible for nearly 2 million deaths, primarily due to long-term complications.
Fichier principal
Vignette du fichier
EUROoCS2024_Abstract-M.Lopes_E.pdf (198.07 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-04536883 , version 1 (08-04-2024)

Identifiers

  • HAL Id : hal-04536883 , version 1

Cite

Mélanie Lopes, Emily Tubbs, Joris Kaal, Fabrice Navarro, Sandrine Lablanche, et al.. Development of an all-human vascularized model of pancreatic islets on-chip: towards personalized medicine for type 1 diabetes. EUROoCS 2024 - The Annual Meeting of the European Organ-on-Chip Society, Jul 2024, Milan, Italy. ⟨hal-04536883⟩
23 View
112 Download

Share

Gmail Facebook X LinkedIn More